Bausch Health Companies Inc.

NYSE:BHC

Drug Manufacturers - Specialty & Generic

Healthcare
$8.73 -2.21%

-$0.11 today

Market cap
$3.27B
Beta
0.41
P/E (TTM)
-1.5
EPS (TTM)
-$3.19
52W Low $4.57High $8.69

Volume 6.83M

Average 1.70M

BHC Pre-Tax Margin

Income before tax as a percentage of revenue.

Bausch Health Companies Inc.NYSE: BHC

Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026

Pre-tax margin widens to 12.2%

Pre-tax margin was 12.2% in Q2 FY2026, up 6.7 pp from a year earlier. On a trailing-twelve-month basis it was -6.7%, down 9.6 pp year over year. Over 3 fiscal years it widened by 5.2 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
12.2%+65.8 pp QoQ
Last fiscal yearDec 2025
3.6%+1.8 pp YoY
LTMJun 2026
-6.7%-9.6 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+6.7 pp——
1 year+1.8 pp——
3 years+5.2 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
3.6%
Year-over-year change
+1.8pp

Pre-Tax Margin vs competitors

How BHC compares with its peers on the latest reported figures

  • BHC's LTM Jun 2026 pre-tax margin of -6.7% is the 7th highest of the 10 companies compared; the peer median is 9.6%.
  • Its year-over-year change of -9.6 pp is the 9th highest of 10, against a peer median of +2.3 pp.
  • Over three fiscal years its change of +5.2 pp compares with a peer median of +13.7 pp.
BHC Competitors Peer median
Pre-Tax Margin for BHC and competitors
Company Period LTM level YoY 3-year change
HCMHUTCHMED (China) LimitedLTM Jun 202588.8% +95.0 pp+179.5 pp
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 202649.7% +1.3 pp-0.8 pp
ANIPANI Pharmaceuticals, Inc.LTM Mar 202612.6% +16.6 pp+30.7 pp
CONConcentra Group Holdings Parent, Inc.LTM Sep 202612.5% +2.3 pp-2.7 pp
HAEHaemonetics CorporationLTM Jun 20269.6% -6.0 pp-2.5 pp
ALVOAlvotechLTM Mar 20267.8% -9.4 pp+687.7 pp
BHCBausch Health Companies Inc.LTM Jun 2026-6.7% -9.6 pp+5.2 pp
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026-15.5% +9.3 pp+13.7 pp
PRGOPerrigo Company plcLTM Jun 2026-38.9% -41.3 pp-27.4 pp
BEAMBeam Therapeutics Inc.LTM Jun 2026-54.7% +606.6 pp+411.7 pp
MLYSMineralys Therapeutics, Inc.FY2025— ——
Peer median (excluding BHC) 9.6%+2.3 pp+13.7 pp

Competitors are the stored peer set for BHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue8.43B8.12B8.76B9.63B10.27B
Cost of Revenue2.39B2.36B2.56B2.78B3.01B
Gross Profit6.04B5.76B6.2B6.84B7.25B
Gross Margin71.6%70.9%70.8%71.1%70.7%
Research & Development473M530M604M634M629M
Selling, General & Admin2.49B2.53B2.9B3.28B3.44B
Operating Expenses5.59B5.31B5.24B5.3B5.07B
Depreciation & Amortization1.55B1.39B1.26B1.27B1.21B
EBITDA3.26B2.88B2.89B3.13B3.18B
EBITDA Margin38.7%35.4%32.9%32.6%31.0%
Operating Income450M454M963M1.55B2.19B
Operating Margin5.3%5.6%11.0%16.1%21.3%
Interest Income7M14M26M33M48M
Interest Expense1.43B1.46B1.33B1.39B1.6B
Other Income / Expenses(1.47B)(583M)(1.35B)(1.38B)(1.82B)
Income Before Tax(1.02B)(129M)(390M)167M367M
Pre-Tax Margin-12.1%-1.6%-4.5%1.7%3.6%
Income Tax Expense(87M)83M221M239M247M
Net Income(948M)(225M)(592M)(46M)157M
Net Margin-11.2%-2.8%-6.8%-0.5%1.5%
EPS (Basic)(2.61)(0.62)(1.62)(0.13)0.43
EPS (Diluted)(2.61)(0.62)(1.62)(0.13)0.43
Weighted Avg Shares358.9M362M364.9M368M370.9M
Weighted Avg Shares (Diluted)358.9M362M364.9M368M375M

Bausch Health Companies Inc.

NYSE:BHC

Intrinsic Alpha fair value

Locked

Current Price

$8.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.